Summary
Updated Aug 30, 2026
Richard S. Levy is Director of Kiniksa Pharmaceuticals International, plc (KNSA). 17 SEC Form 4 filings on record going back to 2024, most recently on 4 August 2026. Most recent open-market trade: sold $42K of MDGL on 22 May 2026. Lifetime open-market sales: $10.61M.
Recent Transactions
20Every recent SEC Form 4 transaction Richard S. Levy has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Richard S. Levy go back to 2024: 17 primary Form 4 filings, an average of 5.7 per year. 39 recorded transactions carry a Rule 10b5-1 flag, meaning they were pre-scheduled under a written trading plan rather than discretionary.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Richard S. Levy files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- BAKER BROS. ADVISORS LP - $60.00M of KOD open-market activity in the last 12 months
- Sanj K. Patel - $39.43M of KNSA open-market activity in the last 12 months
- Kenneth Bate - $8.03M of MDGL open-market activity in the last 12 months
- John F. Paolini - $8.00M of KNSA open-market activity in the last 12 months
- William John Sibold - $7.49M of MDGL open-market activity in the last 12 months
- Eben Tessari - $7.24M of KNSA open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Richard S. Levy?
Richard S. Levy is a corporate insider, tracked as Director of Kiniksa Pharmaceuticals International, plc (KNSA). InsiderAlpha holds 17 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Richard S. Levy submitted recently?
5 primary Form 4 filings in the last 90 days, covering 4 companies.
Has Richard S. Levy been buying or selling stock?
Recorded transactions: 0 open-market purchases and 31 open-market sales ($10.61M) across all tracked filings.
Where can I see all of Richard S. Levy's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Richard S. Levy and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial